Antihypertensive drug prescription trends at the primary health care centres in Bahrain

Pharmacoepidemiology and Drug Safety

Volumn 10, Issue 3, 2001, Pages 219-227

  Jassim Al Khaja, K A ^a   Sequeira, R P ^a   Abdul Wahab, A W M ^a   Mathur, V S ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Antihypertensives; Cost; Drug utilization; International guidelines; Prescription pattern; Primary care

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARDIAC GLYCOSIDE; CHLORTALIDONE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LISINOPRIL; METHYLDOPA; METOPROLOL; NIFEDIPINE; ORAL ANTIDIABETIC AGENT; PROPRANOLOL; THIAZIDE DIURETIC AGENT; TRIAMTERENE;

ADULT; AGE; AGED; ARTICLE; BAHRAIN; CHRONIC DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DRUG COST; DRUG INDICATION; DRUG SAFETY; DRUG UTILIZATION; ESSENTIAL HYPERTENSION; FEMALE; HEALTH CARE COST; HEALTH CENTER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MONOTHERAPY; PHARMACOEPIDEMIOLOGY; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SEX DIFFERENCE; SIDE EFFECT; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BAHRAIN; DRUG UTILIZATION; FEMALE; GUIDELINES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHYSICIANS, FAMILY; PRESCRIPTIONS, DRUG;

EID: 0034903155     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.578     Document Type: Article

References (40)

1. Guidelines for the management of mild hypertension: Memorandum from a WHO/ISH meeting
2. Guidelines for the management of mild hypertension
3. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)
4. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)
5. Report of the Canadian Hypertension Society Consensus Conference, 3: Pharamacological treatment of essential hypertension
6. Management of raised blood pressure in New Zealand: A discussion document
7. Treating mild hypertension
8. Management guidelines in essential hypertension: Report of the second working party of the British Hypertension Society
9. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society
10. Drug utilization in a hospital general medical outpatient clinic with particular reference to antihypertensive and antidiabetic drugs
11. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review
12. Atenolol and plasma renin concentration in hypertensive patient
13. Effect of aging on plasma renin and aldosterone in normal man
14. Adverse reaction to bendrofluazide and propranolol for the treatment of mild hypertension
15. Drug-induced male sexual dysfunction
16. Long-term effects of indapamide: Final results of a two-year Italian multi-centre study in systemic hypertension
17. Biochemical, endocrine, and mineral effects of indapamide in black women
18. Pathogenesis and treatment of hypertension associated with diabetes millitus
19. Long-term experience with indapamide
20. Clinical efficacy and safety of indapamide in the treatment of edema
21. Indapamide: Effects on apoproteins, lipoproteins and glucoregulation in ambulatory diabetic patients
22. Antihypertensive drug prescribing in the Netherlands
23. Who is using antihypertensive drug? A prescription analysis from Finland
24. Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications
25. Angiotensin converting enzyme inhibitor associated cough: A population-based case control study
26. Age related changes of baroreflex function, plasma norepinephrine, and blood pressure
27. Age and pathophysiology-oriented antihypertensive response to calcium antagonists
28. Captopril in the treatment of the elderly hypertensive patient
29. The risk of mycoardial infraction associated with antihypertensive drug therapies
30. Do calcium antagonists cause myocardial infarction?
31. Effects of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients
32. Relevance of intermittent increases in sympathetic activity for adverse outcome on short-acting calcium antagonists
33. Long-term survival and use of antihypertensive medication in older persons
34. FDA Committee rules calcium-channel blockers safe
35. New analysis regarding the safety of calcium channel blockers: A statement for health professionals from the National Heart, Lung and Blood Institute
36. Antihypertensive drugs
37. The 1998 Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure
38. The 1977 Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure
39. Treatment of hypertension in pregnant women